PIPELINE

Clinical Trials

Clinical trials are a fundamental step in the development of Xencor’s monoclonal antibody therapeutics. Clinical trials are research studies that are designed to determine if a medicine is safe and effective for patients. Patients may participate in ongoing clinical trials of Xencor’s investigational drug candidates if they meet certain enrollment criteria.

Information about Xencor’s clinical trials is available at www.clinicaltrials.gov.